cefbuperazone has been researched along with Necrotizing Pyelonephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayakawa, H; Ikegami, T; Nakashima, Y; Noguchi, M; Saikawa, I; Shimizu, H; Takai, A; Yamauchi, H | 1 |
| Aoki, H; Banya, Y; Kubo, T; Niisato, S; Noro, K; Ohhori, T; Okamoto, T; Ujiie, T; Yokota, K; Yoo, T | 1 |
2 other study(ies) available for cefbuperazone and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
[The whole body autoradiographic studies on the distribution of 14C-labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazine-carboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (14C
Topics: Animals; Anti-Bacterial Agents; Autoradiography; Cephalosporins; Cephamycins; Female; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Pyelonephritis; Tissue Distribution | 1982 |
[Clinical experience with cefbuperazone in complicated urinary tract infection].
Topics: Adult; Aged; Cephamycins; Cystitis; Female; Humans; Male; Middle Aged; Pyelonephritis; Urinary Tract Infections | 1987 |